409 related articles for article (PubMed ID: 20677914)
1. The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats.
Zhao BJ; Ke XY; Huang Y; Chen XM; Zhao X; Zhao BX; Lu WL; Lou JN; Zhang X; Zhang Q
J Drug Target; 2011 Jun; 19(5):382-90. PubMed ID: 20677914
[TBL] [Abstract][Full Text] [Related]
2. Anti-tumor and anti-angiogenic effect of metronomic cyclic NGR-modified liposomes containing paclitaxel.
Luo LM; Huang Y; Zhao BX; Zhao X; Duan Y; Du R; Yu KF; Song P; Zhao Y; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(4):1102-14. PubMed ID: 23127332
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
4. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
[TBL] [Abstract][Full Text] [Related]
5. Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain.
Shao K; Huang R; Li J; Han L; Ye L; Lou J; Jiang C
J Control Release; 2010 Oct; 147(1):118-26. PubMed ID: 20609375
[TBL] [Abstract][Full Text] [Related]
6. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.
Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Guo J; Gao X; Su L; Xia H; Gu G; Pang Z; Jiang X; Yao L; Chen J; Chen H
Biomaterials; 2011 Nov; 32(31):8010-20. PubMed ID: 21788069
[TBL] [Abstract][Full Text] [Related]
8. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
9. The therapeutic efficacy of conjugated linoleic acid - paclitaxel on glioma in the rat.
Ke XY; Zhao BJ; Zhao X; Wang Y; Huang Y; Chen XM; Zhao BX; Zhao SS; Zhang X; Zhang Q
Biomaterials; 2010 Aug; 31(22):5855-64. PubMed ID: 20430438
[TBL] [Abstract][Full Text] [Related]
10. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
[TBL] [Abstract][Full Text] [Related]
11. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes.
Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q
J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361
[TBL] [Abstract][Full Text] [Related]
12. The efficiency of tumor-specific pH-responsive peptide-modified polymeric micelles containing paclitaxel.
Zhao BX; Zhao Y; Huang Y; Luo LM; Song P; Wang X; Chen S; Yu KF; Zhang X; Zhang Q
Biomaterials; 2012 Mar; 33(8):2508-20. PubMed ID: 22197569
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
14. Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.
Gong C; Xie Y; Wu Q; Wang Y; Deng S; Xiong D; Liu L; Xiang M; Qian Z; Wei Y
Nanoscale; 2012 Sep; 4(19):6004-17. PubMed ID: 22910790
[TBL] [Abstract][Full Text] [Related]
15. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation.
Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W
Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of paclitaxel and rapamycin individual and dual drug-loaded polymeric micelles in the angiogenic cascade.
Mishra GP; Nguyen D; Alani AW
Mol Pharm; 2013 May; 10(5):2071-8. PubMed ID: 23590802
[TBL] [Abstract][Full Text] [Related]
17. NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells.
Wang X; Wang Y; Chen X; Wang J; Zhang X; Zhang Q
J Control Release; 2009 Oct; 139(1):56-62. PubMed ID: 19470394
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
[TBL] [Abstract][Full Text] [Related]
19. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel.
Liang H; Yang Q; Deng L; Lu J; Chen J
Drug Dev Ind Pharm; 2011 May; 37(5):597-605. PubMed ID: 21469948
[TBL] [Abstract][Full Text] [Related]
20. Polysorbate 80 coated poly (ɛ-caprolactone)-poly (ethylene glycol)-poly (ɛ-caprolactone) micelles for paclitaxel delivery.
Wang Y; Wang C; Gong C; Wang Y; Guo G; Luo F; Qian Z
Int J Pharm; 2012 Sep; 434(1-2):1-8. PubMed ID: 22609127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
